The Index
400 dossiers · 1 need attention
A research screener for every company we cover. Search a name or ticker, then sort and triage dossiers by coverage freshness, our conviction and trading relevance.
Neurotech & BCI
The most-implanted BCI on Earth and the worst-capitalized relative to its peers — a 2008-era electrode bet now owned by a stablecoin issuer, where the moat is two decades of human data and the kill-switch is glial scar tissue. Watching, not buying, until a De Novo/PMA submission and a clean secondary mark say the Tether money actually bought commercialization rather than just runway.
Neurotech & BCI
A blueberry-sized, battery-free epidural stimulator with a Medtronic-grade team and a clean FDA IDE — but it is a single-asset, sub-$30M minnow in a field of nine-figure whales, and its closest peer (Inner Cosmos) already has the clinical lead.